1 | 2024 comments off on | | | | | | 12 | 2.59% |
2 | august 9 2024 comments | | | | | | 5 | 1.08% |
3 | august 8 2024 comments | | | | | | 4 | 0.86% |
4 | 9 2024 comments off | | | | | | 4 | 0.86% |
5 | honors unc rex cardiologist | | | | | | | 3 | 0.65% |
6 | merge qa with genentech | | | | | | | 3 | 0.65% |
7 | to merge qa with | | | | | | | 3 | 0.65% |
8 | exscientia to merge qa | | | | | | | 3 | 0.65% |
9 | holly springs nc 27540 | | | | | | | 3 | 0.65% |
10 | novo vs lilly earnings | | | | | | | 3 | 0.65% |
11 | – holly springs nc | | | | | | | 3 | 0.65% |
12 | rejection novo vs lilly | | | | | | | 3 | 0.65% |
13 | mdma rejection novo vs | | | | | | | 3 | 0.65% |
14 | on mdma rejection novo | | | | | | | 3 | 0.65% |
15 | – durham nc 27703 | | | | | | | 3 | 0.65% |
16 | family honors unc rex | | | | | | | 3 | 0.65% |
17 | development virologybacteriology – durham | | | | | | | 3 | 0.65% |
18 | qa with genentech ceo | | | | | | | 3 | 0.65% |
19 | with genentech ceo and | | | | | | | 3 | 0.65% |
20 | 8 2024 comments off | | | | | | 3 | 0.65% |
21 | hematology raleigh nc – | | | | | | | 3 | 0.65% |
22 | latest on mdma rejection | | | | | | | 3 | 0.65% |
23 | genentech ceo and more | | | | | | | 3 | 0.65% |
24 | virologybacteriology – durham nc | | | | | | | 3 | 0.65% |
25 | – atrium health lci | | | | | | | 2 | 0.43% |
26 | steam ahead’ in dmd | | | | | | | 2 | 0.43% |
27 | unc rex cardiologist with | | | | | | | 2 | 0.43% |
28 | rex cardiologist with 500k | | | | | | | 2 | 0.43% |
29 | ‘full steam ahead’ in | | | | | | | 2 | 0.43% |
30 | it’s ‘full steam ahead’ | | | | | | | 2 | 0.43% |
31 | – charlotte nc 28204 | | | | | | | 2 | 0.43% |
32 | says it’s ‘full steam | | | | | | | 2 | 0.43% |
33 | ft – charlotte nc | | | | | | | 2 | 0.43% |
34 | oncology research specialist – | | | | | | | 2 | 0.43% |
35 | sciences ft – charlotte | | | | | | | 2 | 0.43% |
36 | atrium health lci biostatistics | | | | | | | 2 | 0.43% |
37 | specialist – atrium health | | | | | | | 2 | 0.43% |
38 | research specialist – atrium | | | | | | | 2 | 0.43% |
39 | health lci biostatistics and | | | | | | | 2 | 0.43% |
40 | clinical operations – raleigh | | | | | | | 2 | 0.43% |